To determine if maternal hypoglycemia is associated with adverse perinatal outcome, particularly low birth weight.
It is common in the United States to screen all pregnant females between 24 to 28 weeks for gestational diabetes with the 50-gm glucola followed by a 1-hour plasma glucose measurement. 1 An elevated glucose screen (Ն140 mg/dl%) can be associated with gestational diabetes, which occurs in 2% to 3% of all pregnancies. 2 The diagnosis of gestational diabetes, confirmed by 3-hour glucose tolerance testing, has been shown to be associated with adverse perinatal outcome. 3 Similarly, hypoglycemia has been found to be associated with increased perinatal morbidity. 2, 3 The finding of adverse fetal effects has not been substantiated by more recent reports, and the relationship of a low glucose to maternal weight and other maternal factors have not been well explained.
The goal of this study was to ascertain whether hypoglycemia noted on routine screening for gestational diabetes will select a patient population who is at risk for poor perinatal outcome.
Materials and Methods
In this prospective study, all patients with singleton pregnancies obtaining obstetric care at the University of Mississippi Medical Center were given 50 gm of glucola orally followed by a 1-hour plasma glucose measurement at Ն24 weeks' gestation. To standardize results, participants were instructed to avoid smoking, chewing gum, eating candy, or using cough drops prior to the test. To minimize false low results, patients were observed by clinic staff for compliance with complete ingestion of the 50-gm glucola solution within 5 minutes. If any value was Ն140 mg/dl, a 3-hour, 100-gm oral glucose tolerance test was performed. Gestational diabetes was diagnosed by the standard American College of Obstetricians and Gynecologists criteria. 4 To control for the potential confounding effect of hyperglycemia on perinatal outcome, patients with the diagnosis of diabetes were excluded from analysis. Hypoglycemia was defined as a plasma glucose value of Յ88 mg/dl, as described by Abell et al. 3 Patients were followed prospectively and managed as obstetric indications dictated. All care providers were informed that the test results were normal and were blinded as to whether hypoglycemia was present.
Multiple variables of perinatal outcome were assessed, including demographics (age, race, gravidity, parity), gestational age at screening, patient anthropometric parameters (height, weight, body mass index), medical/obstetric complications (including substance abuse), maternal hypoglycemia symptoms, mode of delivery, gestational age at delivery, maternal length of stay, and neonatal outcome (birth weight, Apgar score, intensive care admission, complications, procedures, length of stay). The main outcome variables were birth weight and the incidence of intrauterine growth restriction assessed at delivery.
Maternal weight was determined before pregnancy and at delivery. A patient was classified as underweight if her calculated prepreg-Current Concepts
nancy body mass index was Ͻ19.8 kg/m 2 according to guidelines established by the National Academy of Sciences. 5 An adolescent pregnancy was defined as a maternal age at delivery of Յ19 years.
In this investigation, fetal growth restriction was defined as birth weight less than the 10th percentile according to nationally established criteria adjusted for race, gender, parity, and gestational age at delivery. 6 Assuming an ␣ error of 0.05 and a ␤ error of 0.2, a sample size of 339 patients would be needed to detect an increase of 10% in the incidence of infant growth restriction.
A p value of Ͻ0.05 was established as the level of statistical significance. However, to control for the multiple variable comparisons, the Bonferroni correction was applied as indicated. Interval data included 18 variables that were analyzed using a paired t-test with a p value adjusted to Ͻ0.004 (0.05/12 variables). Nominal data included 25 variables that were analyzed using -squared or Fisher exact tests depending on cell size with p adjusted to Ͻ0.002 (0.05/25 variables). Ordinal data were analyzed using the Mann-Whitney rank-sum test.
Results
During the fiscal year 1995, 426 singleton pregnancies underwent screening for gestational diabetes with the 50-gm, 1-hour glucola test. The plasma glucose mean value was 99.8 Ϯ 22.7 mg/dl with a median of 97 mg/dl and a range of 50 to 199 mg/dl (Figure 1 ). Forty-six failed to return to our clinic, were delivered at an outside hospital, or were lost to follow-up. These 46 patients were evenly distributed between the study and control groups. Also excluded from analysis were 16 patients who were diagnosed with gestational diabetes. Of the remaining 364 patients, 116 pregnancies were found to have hypoglycemia on the 1-hour glucola screening, whereas the remaining 248 were euglycemic (89 to 139 mg/dl) and served as the control group (Figure 2) . Control patients and the hypoglycemic women were found to be similar with respect to maternal demographics, and no women complained of symptoms of hypoglycemia (dizziness, fainting, hunger, etc.) at testing.
Perinatal outcome data are summarized in Table 1 . When the maternal glucose value was below 88 mg/dl, the patients tended to weigh less at the beginning of pregnancy (146 Ϯ 42 lbs) and at delivery (178 Ϯ 44 lbs) compared to the control group (163 Ϯ 47, p ϭ 0.001; 194 Ϯ 51 lbs, p ϭ 0.003; respectively). However, the total weight gain during pregnancy was similar between the two groups. There was no difference between groups with respect to the rate of substance abuse (tobacco, alcohol, and illicit drugs). Mothers in the hypoglycemic group tended to be younger, nulliparous, and underweight when compared with the control parturients. Women with hypoglycemia were tested on the average slightly earlier (28.7 vs 29.7 weeks), but this was not considered clinically significant. There was a tendency toward adolescent pregnancies to be in the hypoglycemic group, but none of these variables met the criteria for statistical significance after post hoc analysis with the Bonferroni correction.
No other maternal variables achieved statistical significance. None of the neonatal variables analyzed, including the main outcome variables of birth weight and the rate of growth restriction, were different between the groups.
Comment
The premise of this study was to determine if maternal hypoglycemia, noted on routine prenatal glucose screening, is associated with adverse perinatal outcome. An Australian study, by Abell et al., 3 investigated this possible association in a prospective analysis of 2000 patients (50% indigent and 50% private) who had 3-hour, 50-gm glucose testing between 32 to 34 weeks' gestation. The 1-hour, 50-gm glucola screening value in the current study was considered analogous to the 1-hour value in the Australian investigation. They found that maternal hypoglycemia was associated with fetal growth restriction and low birth and placental weights. In the current investigation, the birth weight among hypoglycemic women (3029 Ϯ 563) and the incidence of growth restriction (7.8% 9 ⁄116) was not different from euglycemic patients (3068 Ϯ 636, 8.9% 22 ⁄248, respectively). In a post hoc analysis of our data, the incidence of growth restriction remained constant despite lowering the threshold of hypoglycemia to 77 mg/dl, which is one standard deviation below our population mean (99.8 Ϯ 22.7 mg/dl). There are several potential reasons for the discrepancy of results noted from this investigation as compared to the previously described Australian study. 3 Maternal tobacco abuse has been described as an independent risk factor for growth-restricted infants. 7 However, all forms of substance abuse, such as alcohol, cocaine, marijuana, and polysubstance abuse should be considered as high-risk behaviors for growth abnormalities, especially in urban, indigent populations. Low prepregnancy maternal weight and poor weight gain during pregnancy have also been associated with low birth weight per gestational age. 7 In our study, total maternal weight gain during pregnancy was similar between both groups. However, hypoglycemia was associated with maternal low prepregnancy body mass index.
Adolescent pregnancies, particularly first gestations, are also risk factors for fetal growth restriction. This could be secondary to these patients being less educated, and thus being less likely to have received early or adequate prenatal care. Another factor for an increased risk for growth restriction is that teenage patients compete with the developing fetus for essential nutrients. 8 Certain ethnic minorities, such as Asians and African Americans, have been associated with growth-restricted births. 7 Our total study population consisted of 81% African American, 17% Caucasian, and 2% other ethnic minorities. In addition, these patients were nearly 100% indigent, 38.2% nulliparous, 30.2% adolescent, 8.7% underweight, and 4.4% substance abusers. The Australian study comprised 50% private and 50% indigent in a predominantly Caucasian population. 3 However, the rates of potential confounding variables such as maternal substance abuse, age, weight, and parity were not reported. Further analysis reveals that their rate of fetal growth restriction among euglycemic patients was 8.5%, which is very similar to our rate of 8.9%. In hypoglycemic patients based on a 1-hour, 50-gm plasma glucose value, the Australian rate for fetal growth restriction was slightly higher at 9.8% compared to 7.8% in the current study. The demographic differences and the potential for multiple confounding variables to exert influence on the population rate of growth restriction could explain the disparity in results between our data and the Australian study. 3 Although multiple variables were assessed, there was no statistically significant factor linking hypoglycemia with poor perinatal outcome in this study. Specifically, the finding of hypoglycemia in our population does not appear to be predictive of growth restriction. However, it may be one part of a complex problem that has a multifactorial etiology. Hypoglycemia should alert the clinician to investigate the multiple ethnic, socioeconomic, and dietary factors associated with growth restriction and low birth weight infants. 
